CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
“Our diagnostic solutions for COVID-19 and flu will help inform timely diagnosis and, ultimately, may contribute to faster and clinically appropriate patient management and treatment,” Dave Hickey, president of life sciences for BD, said in a press release. “In addition, the new information provided on the test’s ability to detect the U.K. and South African variants provides helpful guidance to health care practitioners as we look to identify and contain these new strains.”
The BD Max can process hundreds of samples over a 24-hour period. The BD SARS-CoV-2/Flu kits are now available for order in the United States and Europe.
Pages: 1 2